1. Comparison of metabolic alterations, hepatic and cardiovascular damage between primary NAFLD and HIV-associated NAFLD: Role of low visceral adiposity. (March 2023) Authors: Lombardi, R.; Cinque, F.; Cespiati, A.; Marchesi, L.; Francione, P.; Fatta, E.; Bertelli, C.; Pisano, G.; Oberti, G.; Colavolpe, L.; Alletto, F.; Dongiovanni, P.; Meroni, M.; Bozzi, G.; Bandera, A.; Fracanzani, A.L. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S39 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. SGLT2 inhibitors improve hepatic fibrosis assessed by Fibroscan in NAFLD patients with type 2 diabetes: A five-year follow-up study. (March 2023) Authors: Lombardi, R.; Cespiati, A.; Mantovani, A.; Maffi, G.; Del Zanna, E.; Francione, P.; Cinque, F.; Villani, R.; Maffeis, C.; Passigato, N.; Orsi, E.; Grancini, V.; Pisano, G.; Airaghi, L.; Targher, G.; Serviddio, G.; Fargion, S.; Fracanzani, A.L. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The impact of metabolic comorbidities and alcohol consumption on FIB-4 and NFS performance in MAFLD: A multicentric preliminary data. (March 2023) Authors: Cespiati, A.; Lombardi, R.; Smith, D.; Carvalhana, S.; Cinque, F.; Policarpo, S.; Bertelli, C.; Pisano, G.; Fracanzani, A.L.; Cortez-Pinto, H. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗